IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aisling Capital Management LP

Q2 2023 Holdings

Filed 2023-08-11 | 16 holdings | $204.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
BridgeBio Pharma Inc. (Bbio)(BBIO)COM10806X102$104.4M6,068,12551.1%
Verona Pharma plc (Vrna)(VRNA)SPONSORED ADS925050106$23.6M1,115,35211.6%
Syndax Pharmaceuticals, Inc. (Sndx)(SNDX)COM87164F105$21.5M1,025,00010.5%
Biomea Fusion Inc (Bmea)(BMEA)COM09077A106$17.5M798,7578.6%
Monte Rosa Therapeutics Inc (Glue)(GLUE)COM61225M102$10.1M1,472,3314.9%
Reneo Pharmaceuticals Inc (Rphm)(RPHM)COM75974E103$5.8M886,0752.8%
Nuvation Bio Inc. (Nuvb)(NUVB)COM CL A67080N101$4.6M2,541,0092.2%
Aclaris Theraputics Inc (Acrs)(ACRS)COM00461U105$4.5M434,4552.2%
Elevation Oncology Inc (Elev)COM28623U101$4.3M2,834,9102.1%
Spruce Biosciences, Inc. (Sprb)COM85209E109$2.6M1,205,5111.3%
Poseida Therapeutics Inc. (Pstx)(PSTXUSD)COM73730P108$1.8M1,043,2670.9%
Marker Therapeutics, Inc. (Mrkr)(MRKR)COM57055L206$974.3K314,2860.5%
Avrobio, Inc. (Avro)COM05455M100$959.4K1,009,7790.5%
Aeglea Biotherapeutics Inc (Agle)(AGLEUSD)COM00773J103$761.9K1,691,1510.4%
Viracta Therapeutics Inc (Virx)COM92765F108$406.9K288,5710.2%
Atreca Inc. (Bcel)(BCELUSD)CL A COM04965G109$379.9K387,6530.2%